Home > Journals > Minerva Respiratory Medicine > Past Issues > Minerva Pneumologica 2011 June;50(2) > Minerva Pneumologica 2011 June;50(2):111-28

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

  CONTROVERSIES AND UPDATES IN RESPIRATORY MEDICINE 

Minerva Pneumologica 2011 June;50(2):111-28

Copyright © 2011 EDIZIONI MINERVA MEDICA

language: English

Exercise strategies for chronic respiratory diseases

Kortianou E. A. 1, 2, Nasis I. G. 1, Vogiatzis I. 1

1 Department of Physical Education and Sports Sciences, National and Kapodistrian University of Athens, Athens, Greece 2 Physiotherapy Department, Technological Educational Institute of Lamia, Lamia, Greece


PDF


Chronic respiratory diseases (CRDs) are characterized by exertional dyspnea, exercise limitation and reduced quality of life. The role of exercise training is essential for improving symptoms, physical function and health related quality of life. The majority of the research provides evidence that supports the effectiveness of exercise mainly in patients with respiratory disorders such as chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and cystic fibrosis (CF). However, growing evidence supports the use of exercise training as an effective and safe intervention for patients with interstitial lung disease (ILD) and idiopathic pulmonary arterial hypertension (iPAH). Despite the lack of clinical guidelines for exercise training in iPAH, several recent studies have shown effectiveness of exercise in amelioration of dyspnea and improvement in functional capacity in patients with iPAH. In the others CRD the overall process for generating clinical guidelines has been addressed in numerous recently published documents which suggest an approach to management. The aim of this review was to establish the effects of different exercise training strategies on exercise capacity, dyspnoea sensations and quality of life in the following chronic respiratory diseases: chronic obstructive pulmonary disease, cystic fibrosis, interstitial lung diseases and idiopathic pulmonary arterial hypertension.

top of page